Login / Signup

Efficacy of switching from teriparatide to zoledronic acid or denosumab on bone mineral density and biochemical markers of bone turnover in older patients with severe osteoporosis: a real-life study.

Giorgia DitoMarina LugaresiChiara DegradiGregorio GuabelloMatteo LonghiSabrina Corbetta
Published in: Endocrine (2023)
Sequential TPT + ZOL therapy is likely to increase bone mineralization at the lumbar level and to stabilize it at the femoral level, similarly to what obtained with the sequential TPT+Dmab. Both ZOL and Dmab are suggested to be effective sequential treatments after TPT.
Keyphrases
  • bone mineral density
  • postmenopausal women
  • body composition
  • minimally invasive
  • early onset
  • middle aged
  • community dwelling
  • mesenchymal stem cells
  • bone marrow
  • drug induced